- Case report
- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
Use of endovascular embolization to treat a ruptured arteriovenous malformation in a pregnant woman: a case report
© Jermakowicz et al; licensee BioMed Central Ltd. 2012
Received: 26 July 2011
Accepted: 23 April 2012
Published: 23 April 2012
Pregnancy has been linked to increased rates of arteriovenous malformation rupture. This link remains a matter of debate and very few studies have addressed the management of arteriovenous malformation in pregnancy. Unruptured arteriovenous malformations in pregnant woman generally warrant conservative management due to the low rupture risk. When pregnant women present with ruptured arteriovenous malformation, however, surgery is often indicated due to the increased risk of re-rupture and associated mortality. Endovascular embolization is widely accepted as an important component of contemporary, multimodal therapy for arteriovenous malformations. Although rarely curative, embolization can facilitate subsequent surgical resection or radiosurgery. No previous reports have been devoted to the endovascular management of an arteriovenous malformation in a pregnant woman.
A 23-year-old Caucasian woman presented with headache and visual disturbance after the rupture of a left parieto-occipital arteriovenous malformation in the 22nd week of her pregnancy. After involving high-risk obstetric consultants and taking precautions to shield the fetus from ionizing radiation, we proceeded with a single stage of endovascular embolization followed soon after by open surgical resection of the arteriovenous malformation. There were several goals for the angiography in this patient: to better understand the anatomy of the arteriovenous malformation, including the number and orientation of feeding arteries and draining veins; to look for associated pre-nidal or intra-nidal aneurysms; and to partially embolize the arteriovenous malformation via safely-accessible feeders to facilitate surgical resection and minimize blood loss and operative morbidity.
From our experience and review of the literature, we maintain that ruptured arteriovenous malformations in pregnancy may be managed in a similar manner to those in non-gravid women. Precautions should be taken to reduce the operative time and exposure of the fetus to ionizing radiation and contrast agents.
The rupture of an intracranial arteriovenous malformation (AVM) in pregnancy is a rare occurrence, but may have fatal consequences . A link between AVM rupture and pregnancy has been proposed; it may be caused by the increased cardiac output or circulatory effects of the elevated estrogen levels . However, in some series the reported hemorrhage rate from AVMs in pregnancy is around 0.6% to 3.5%, which is similar to the 2% to 4% rate in non-pregnant women. Due to this low risk of hemorrhage, most authors recommend conservative management of unruptured AVMs during pregnancy [2, 3]. An aggressive approach is warranted, however, when pregnant patients present with a ruptured AVM. The risk of re-bleed during the same pregnancy (27% to 30%) is greater than the risk of re-bleed in non-gravid women within one year of their initial bleed (6%). These bleeds in pregnant women are associated with high maternal and fetal mortality (10% to 40%) [2, 4]. Thus, despite the potentially deleterious effects of radiation on the fetus, surgical management is generally indicated when pregnant women present with a ruptured AVM.
Historically, ruptured AVMs in pregnant women have been managed surgically with great success [2, 3, 5]. In patients presenting with AVM rupture, resection has been shown to be associated with lower rates of maternal and fetal mortality when compared to conservative management [4, 6]. More recently, with advances in endovascular technology, embolization of AVMs has been used as an adjuvant to surgery, if not as a primary mode of treatment, with much success. However, the role of endovascular embolization in the management of AVM rupture in pregnant women has not been established.
Here, we report the case of a 22-week-pregnant woman who presented with a symptomatic ruptured AVM, treated with embolization followed by surgical resection. There were several goals for the angiography in this patient: to better understand the anatomy of the AVM, including the number and orientation of feeding arteries and draining veins; to look for associated pre-nidal or intra-nidal aneurysms; and to partially embolize the AVM via safely-accessible feeders to facilitate surgical resection and minimize blood loss and operative morbidity.
Three weeks later, our patient was brought to the neurosurgical operating suite and anesthetized by obstetric anesthesia. The obstetrics team was also in the room and was monitoring the fetus during the entire procedure. After insertion of a right femoral sheath in the standard fashion, our patient was put in the prone position for the craniotomy. Stealth guidance was used to plan our craniotomy prior to incision. The craniotomy was centered over the left parieto-occipital AVM and using the standard microsurgical technique we proceeded to safely and effectively resect the AVM. Once we were satisfied with our resection we performed an intraoperative cerebral angiogram. Once again, all possible measures were taken to reduce radiation and contrast exposure to mother and fetus. The angiogram revealed complete resection of the AVM. The wound was closed in the standard fashion and our patient was transferred to the neurosurgical intensive care unit.
Our patient recovered well without complications and was discharged home on postoperative day two. At the time of this submission, our patient had delivered her baby at 39 weeks via a normal vaginal delivery at an outside hospital without the need for high-risk obstetric personnel. Both mother and baby are healthy and with no complications related to the procedures.
Given the increased risk of re-hemorrhage in pregnant mothers that present with AVM bleed and the high associated maternal and fetal mortality [2, 6, 10], aggressive management of these lesions during pregnancy is warranted. These patients should be treated similarly to their non-gravid counterparts. There are also several additional risk factors that increase the likelihood of AVM hemorrhage and may be considered when indications for surgery are not clear. These include hypertension, increased age, coagulopathy, disseminated intravascular coagulation and recent use of vasoactive substances . Of these risk factors, our patient had untreated gestational hypertension, which is the single factor most closely linked with AVM rupture .
Endovascular embolization has been used with increasing frequency for the treatment of AVMs in the general population. Embolization may either be performed as stand-alone treatment or as part of a multimodal therapy. When embolization is used alone for the definitive treatment of AVMs, the reported cure rates are 5% to 28%, lower than the cure rates of surgical resection (80% to 95%) and radiosurgery (65% to 85%). In addition, stand-alone embolic therapy has relatively high morbidity (4% to 9%) and mortality (2% to 4%) when compared to surgical resection and radiosurgery. These complications are due, largely, to the fact that the more complicated AVMs tend to be the ones that receive endovascular treatment [7, 9, 12]. The utility of endovascular embolization, however, becomes more apparent when used prior to surgical resection. In such cases the embolization typically reduces the size of the AVM and may improve safety during the subsequent resection. For instance, it is thought that reducing the AVM in a step-wise fashion with embolization lowers the risks for normal perfusion pressure break-through syndrome, where a diversion of the AVM's blood towards other vessels leads to cerebral edema and hemorrhage . Also, because embolization during multimodal therapy is less aggressive than during stand-alone therapy, the morbidity (4% to 6%) and mortality (0% to 2%) tend to be lower [8, 13, 14]. There is a lack of studies that compare cure rates and complications of endovascular embolization with surgery versus surgery alone. In a retrospective study, Deruty et al. had an 82% cure rate in 19 patients managed with surgery alone and a 100% cure rate in 19 patients managed with both embolization and surgery, suggesting a benefit to embolization before surgery.
For small AVMs or lesions in easily accessible areas, surgery alone may be suitable. However, when lesions are large, in deep areas or have many feeders, embolization before surgery may increase the cure rate while reducing the overall risk. When these procedures are performed in pregnant women, proper shielding of the abdomen and minimizing the use of ionizing radiation are of particular importance. The use of selective angiography, for example, minimizes fluoroscopy time and radiation exposure. Visipaque™ is not contraindicated in pregnancy; however, use of half strength contrast may further increase safety. In addition, while Onyx® embolization was effective in this case, an argument could be put forth for using N-butyl 2-cyanoacrylate, for which the actual embolization process is considerably quicker. The involvement of a high-risk obstetric team with fetal heart monitoring capability also provides valuable protection. Experience with intravascular procedures in pregnant women will further help guide management of this rare, but important patient population.
The rupture of an AVM in a pregnant patient is a serious complication that requires surgical intervention. The use of endovascular embolization with surgical resection is safe in these patients, particularly when measures are taken to protect the fetus, and may provide benefits over the use of surgery or embolization alone.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Perquin DA, Kloet A, Tans JT, Witte GN, Dörr PJ: Intracranial arteriovenous malformations in pregnant women. Ned Tijdschr Geneeskd. 1999, 143: 497-500.PubMedGoogle Scholar
- Trivedi RA, Kirkpatrick PJ: Arteriovenous malformations of the cerebral circulation that rupture in pregnancy. J Obstet Gynaecol. 2003, 23: 484-488. 10.1080/0144361031000153684.View ArticlePubMedGoogle Scholar
- Fujita K, Tsunoda H, Shigemitsu S, Kubo T: Clinical study on the intracranial arteriovenous malformation associated with pregnancy. Nippon Sanka Fujinka Gakkai Zasshi. 1995, 47: 1359-1364.PubMedGoogle Scholar
- Robinson JL, Hall CS, Sedzimir CB: Arteriovenous malformations, aneurysms, and pregnancy. J Neurosurg. 1974, 41: 63-70. 10.3171/jns.1974.41.1.0063.View ArticlePubMedGoogle Scholar
- Couldwell SM, Kraus KL, Couldwell WT: Regression of cerebral arteriovenous malformation in the puerperium. Acta Neurochir (Wien). 2011, 2: 359-362.View ArticleGoogle Scholar
- Schwartz J, Lynbrook NY: Pregnancy complicated by subarachnoid hemorrhage. Am J Obstet Gynecol. 1951, 62: 539-547.View ArticlePubMedGoogle Scholar
- Mounayer C, Hammami N, Piotin M, Spelle L, Benndorf G, Kessler I, Moret J: Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients. Am J Neuroradiol. 2007, 28: 518-523.PubMedGoogle Scholar
- Natarajan SK, Ghodke B, Britz GW, Born DE, Sekhar LN: Multimodality treatment of brain arteriovenous malformations with microsurgery after embolization with onyx: single-center experience and technical nuances. Neurosurgery. 2008, 62: 1213-1325. 10.1227/01.neu.0000333293.74986.e5.View ArticlePubMedGoogle Scholar
- Panagiotopoulos V, Gizewski E, Asgari S, Regel J, Forsting M, Wanke I: Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx). Am J Neuroradiol. 2009, 30: 99-106. 10.3174/ajnr.A1629.View ArticlePubMedGoogle Scholar
- Robinson JL, Hall CS, Sedzimir CB: Subarachnoid hemorrhage in pregnancy. J Neurosurg. 1972, 36: 27-33. 10.3171/jns.1972.36.1.0027.View ArticlePubMedGoogle Scholar
- Barrow DL, Reisner A: Natural history of intracranial aneurysms and vascular malformations. Clin Neurosurg. 1993, 40: 3-39.PubMedGoogle Scholar
- Katsaridis V, Papagiannaki C, Aimar E: Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients. Neuroradiology. 2008, 50: 589-597. 10.1007/s00234-008-0382-x.View ArticlePubMedGoogle Scholar
- Weber W, Kis B, Siekmann R, Jans P, Laumer R, Kühne D: Preoperative embolization of intracranial arteriovenous malformations with Onyx. Neurosurgery. 2007, 61: 244-252. 10.1227/01.NEU.0000255473.60505.84.View ArticlePubMedGoogle Scholar
- van Rooij WJ, Sluzewski M, Beute GN: Brain AVM embolization with Onyx. Am J Neuroradiol. 2007, 28: 172-177.View ArticlePubMedGoogle Scholar
- Deruty R, Pelissou-Guyotat I, Amat D, Mottolese C, Bascoulergue Y, Turjman F, Gerard JP: Complications after multidisciplinary treatment of cerebral arteriovenous malformations. Acta Neurochir (Wien). 1998, 138: 119-131.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.